Agios Pharmaceuticals (AGIO)

Celgene buying out Agios would make sense but either way the company's work on cellular metabolism and gene deleting is interesting the bulls the most. Agios stock is a good buy on its own merits.

7 ‘Strong Buy’ Stocks With 100% Wall Street Support

By Harriet Lefton, Writer, TipRanks Nov 17, 2017

These seven rare stocks have received only "buy" ratings from Wall Street's best analysts, with more upside predicted to come.

Liberty Sirius XM Group (LSXMK) Lead 12 Activist Investor Reports

By Fintel Apr 25, 2017

Recent 13-D and 13-G filings are windows into activist investors activity. We look at Liberty Sirius XM Group and 11 others

40 Biotechnology Stocks to Sell Now

By Portfolio Grader Dec 12, 2016

This week, the overall grades of 40 Biotechnology stocks are lower, according to the Portfolio Grader database. Each of these rates a "D" ("sell") or "F" overall ("strong sell").

40 Biotechnology Stocks to Sell Now

By Portfolio Grader Dec 5, 2016

The overall ratings of 40 Biotechnology stocks are down on Portfolio Grader this week. Each of these rates a "D" ("sell") or "F" overall ("strong sell").

Why Agios Pharmaceuticals Inc (AGIO), LPL Financial Holdings Inc (LPLA) and Humana Inc (HUM) Are 3 of Today’s Worst Stocks

By James Brumley, InvestorPlace Feature Writer Dec 5, 2016

Agios (AGIO), LPL Financial (LPLA) and Humana (HUM) were wishing the weekend could have lasted one more day on Monday.

10 Stocks That Should Be in Your Portfolio Right Now

By Johnson Research Group Sep 22, 2016

These 10 stocks to buy are the perfect way to load up before the seasonally strong October-through-December period.

22 Biotechnology Stocks to Sell Now

By Portfolio Grader Jul 11, 2016

This week, 22 Biotechnology stocks are worse, according to the Portfolio Graderdatabase. Each of these rates a "D" ("sell") or "F" overall ("strong sell").

7 Healthcare Stocks That Are Portfolio Poison

By Louis Navellier, Editor, Growth Investor Jan 15, 2016

The market loves to watch a stock grow as much as a parent loves to watch their child grow. Buy, much like toddlers, these healthcare stocks are tumbling.

3 Stocks With Plunging Prices

By James Brumley, InvestorPlace Feature Writer Dec 23, 2014

Here's why Agios Pharmaceuticals Inc (AGIO), Zulily Inc (ZU) and Aruba Networks, Inc. (ARUN) are three of today's worst stocks.

5 Overhyped Stocks to Sell Now

By James Brumley, InvestorPlace Feature Writer Dec 5, 2014

Zoetis, Apple, Yahoo!, and a couple of other overhyped stocks are ripe for pullbacks. Don't wait for the meltdown to start before heading for the exit.

11 Biotechnology Stocks to Buy Now

By Portfolio Grader Nov 12, 2014

This week, 11 biotechnology stocks are improving their overall ratings on Portfolio Grader. Each of these stocks is rated an "A" ("strong buy") or "B" overall ("buy").

9 Biotechnology Stocks to Buy Now

By Portfolio Grader Aug 27, 2014

This week, nine biotechnology stocks are improving their overall ratings on Portfolio Grader. Each of these stocks is rated an "A" ("strong buy") or "B" overall ("buy").

8 Biotechnology Stocks to Buy Now

By Portfolio Grader Aug 6, 2014

The grades of eight biotechnology stocks are on the rise this week on Portfolio Grader. Each of these stocks is rated an "A" ("strong buy") or "B" overall ("buy").

25 Small-Cap Stocks to Buy

By Jeff Reeves Jul 23, 2014

This list of 25 small-cap stocks to buy includes some tech stocks and consumer plays that could add 25% in the next year.

Agios Pharmaceuticals GAAP EPS of -$6.33 misses by $0.07, revenue of $26.82M misses by $0.9M (NASDAQ:AGIO)

From Seeking Alpha Feb 15, 2024

Agios Pharmaceuticals reports Q4 2023 financial results, with a missed GAAP EPS by $0.07 and revenue of $26.82M missing by $0.9M.

AIM stock dips amid mixed results for post-COVID fatigue therapy (NASDAQ:AGIO)

From Seeking Alpha Feb 8, 2024

AIM ImmunoTechn (AIM) stock dipped after the company reported mixed topline results from a Phase 2 study of Ampligen for post-COVID fatigue. Read more here.

Investors growing more bullish on SMID cap biotech stocks (NASDAQ:ALNY)

From Seeking Alpha Feb 4, 2024

Investors are more bullish about small and mid-cap biotech stocks this year, with Merus (MRUS) and Fusion (FUSN) viewed as most likely to outperform, according to TD Cowen.

CRISPR, bluebird stocks slide as Agios rallies on thalassemia study (NASDAQ:AGIO)

From Seeking Alpha Jan 3, 2024

Shares of CRISPR (CRSP) and bluebird bio (BLUE) were trading significantly lower Wednesday afternoon after Agios Pharmaceuticals (AGIO) announced positive Phase

Why Shares of Schrödinger Rose This Week

From The Motley Fool Jun 16, 2023

Interest in the company's AI platform continues to drive the stock.

Analysts Offer Insights on Healthcare Companies: Gilead Sciences (GILD) and Agios Pharma (AGIO)

From TipRanks Dec 1, 2022

Analysts fell to the sidelines weighing in on Gilead Sciences (GILD – Research Report) and Agios Pharma (AGIO – Research Report) with neutral ratin...

Agios Pharmaceuticals (AGIO)

AGIO Stock Earnings: Agios Pharmaceuticals Beats EPS, Misses Revenue for Q1 2024

The 3 Best Biotech Stocks to Buy Now: Q2 Edition

7 Biotech Stocks Fighting America’s Deadliest Diseases

Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Wednesday

Top 5 Stocks for 2024

Louis Navellier's Total Grade

Is ? a BUY?

Louis Navellier's Total Grade

Louis Navellier's Total Grade

Fundamental Grade

Quantitative Grade

Agios Pharmaceuticals (AGIO)

Top 5 Stocks for 2024

Louis Navellier's Total Grade

Is ? a BUY?

Louis Navellier's Total Grade

Louis Navellier's Total Grade

Fundamental Grade

Quantitative Grade

AGIO Stock Predictions, Articles, and Agios Pharmaceuticals News

Subscriber Sign in